Eli Lilly and Company (LLY) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Eli Lilly And Company.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.655 Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q1 2026 earnings 00:00:04.655 -- 00:00:08.579 conference call. At this time, all participants are in a listen-only mode. 00:00:08.579 -- 00:00:12.483 Later, we will be conducting a question and answer session and instructions will be given 00:00:12.483 -- 00:00:17.807 at that time. Should you require assistance during the call, please press star then zero 00:00:17.807 -- 00:00:21.791 and an operator will assist you offline. I would now like to turn the conference over 00:00:21.791 -- 00:00:26.015 to your host, Mike Zappar, Senior Vice President of Investor Relations. 00:00:26.015 -- 00:00:28.395 Please go ahead. 00:00:28.818 -- 00:00:34.524 Good morning. Thank you for joining us for Eli Lilly and Company's Q1 2026 earnings call. 00:00:34.524 -- 00:00:37.868 I'm Mike Sabar, Senior Vice President of Investor Relations. 00:00:37.868 -- 00:00:41.653 Joining me on today's call are Dave Ricks, Lilly's Chair and CEO. 00:00:41.653 -- 00:00:44.557 Lucas Montarse, Chief Financial Officer. Dr. 00:00:44.557 -- 00:00:47.782 Dan Skowromski, Chief Scientific and Product Officer. 00:00:47.782 -- 00:00:50.425 Adrian Brown, President of Lilly Immunology. 00:00:50.425 -- 00:00:53.490 Dr. Carol Ho, President of Lilly Neuroscience. 00:00:53.490 -- 00:00:57.288 Ilya Yufa, President of Lilly USA and Global Customer Capabilities. 00:00:57.288 -- 00:01:00.893 Jake Van Narden, President of Lillian College, Head of Business Development. 00:01:00.893 -- 00:01:03.557 Patrick Gonson, President of Lilly International. 00:01:03.557 -- 00:01:07.544 And Ken Custer, President of Lilly Cardiometabolic Health. 00:01:07.544 -- 00:01:11.309 We're also joined by the investor relations team, Kim Grif...